Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

New painkillers stalk Zohydro
Medical Marketing & Media
Thursday, May 1, 2014 - 9:18am
tags:
Zohydro, Zogenix, Purdue Pharma, hydrocodone, painkillers
U.K. Lawmakers Seek Ways to Challenge Pfizer Move on AstraZeneca
Bloomberg
Thursday, May 1, 2014 - 8:50am
tags:
UK, Pfizer, M&A, AstraZeneca
Mylan's Q1 profit, sales grow; signals "substantial transaction" this year
First Word Pharma
Thursday, May 1, 2014 - 8:49am
tags:
Mylan, earnings
Shire declines to comment on any specifics of 'M&A frenzy'
Reuters
Thursday, May 1, 2014 - 8:43am
tags:
M&A, Shire, Allergan
Sanofi's MS team rebuilds its case for the FDA-rejected MS drug Lemtrada
Fierce Biotech
Thursday, May 1, 2014 - 8:41am
tags:
Lemtrada, Sanofi, MS, multiple sclerosis
Innate Pharma And The Role Of The Innate Immune System In Cancer Immunotherapy
Seeking Alpha
Thursday, May 1, 2014 - 8:39am
tags:
Innate Pharma S.A., cancer immunotherapy
Global antibiotics threat: What’s big pharma doing?
CNBC
Thursday, May 1, 2014 - 8:38am
tags:
Big Pharma, antibiotic resistance, antibiotics
AstraZeneca Will Grow as Independent Company: Chairman
Bloomberg
Thursday, May 1, 2014 - 8:31am
tags:
AstraZeneca, Leif Johansson, Pfizer, M&A
Novo Nordisk profit up 8%; warns on sales growth
Marketwatch
Thursday, May 1, 2014 - 8:29am
tags:
earnings, Novo Nordisk
Merrimack cancer drug combination improves survival in study
Yahoo/Reuters
Thursday, May 1, 2014 - 8:27am
tags:
Merrimack Pharmaceuticals, metastatic pancreatic cancer, MM-398
Teva Pharmaceutical Q1 profit up, slightly tops estimates
Yahoo/Reuters
Thursday, May 1, 2014 - 8:24am
tags:
earnings, Teva Pharmaceuticals
Five Small Biotech Stocks Analysts Think Will Triple
Forbes
Thursday, May 1, 2014 - 7:23am
tags:
Arrowhead Research, ChemoCentryx, Ziopharm, TherapeuticsMD, Dynavax
Pfizer-AstraZeneca Play Will Change the Global Pharma Landscape Forever
TheStreet.com
Wednesday, April 30, 2014 - 7:06pm
tags:
Pfizer, AstraZeneca, M&A
Endo to pay $830M to settle pelvic mesh lawsuits
Yahoo/AP
Wednesday, April 30, 2014 - 7:05pm
tags:
pelvic mesh, vaginal mesh, devices, Endo Health Solutions
Would Merck Be the Best Buyer for AstraZeneca?
Motley Fool
Wednesday, April 30, 2014 - 6:46pm
tags:
M&A, AstraZeneca, Merck, Pfizer, diabetes
With Big Pharma mergers in the works, whose SG&A costs look ripe for cutting?
Fierce Pharma Marketing
Wednesday, April 30, 2014 - 1:10pm
tags:
layoffs, M&A, Novartis, GSK, Pfizer, AstraZeneca
WellPoint says hepatitis C drugs Q1 cost was $50 mln
Yahoo/Reuters
Wednesday, April 30, 2014 - 1:08pm
tags:
hepatitis C, drug costs, Wellpoint, Sovaldi, Gilead Sciences
No Longer King Of The North, Pfizer Looks To Recapture Crown
Forbes
Wednesday, April 30, 2014 - 1:03pm
tags:
Pfizer, M&A
Members of Parliament to grill Pfizer chiefs over bid for AstraZeneca
Independent, UK
Wednesday, April 30, 2014 - 1:01pm
tags:
M&A, UK, Pfizer, AstraZeneca
Synergy Pharmaceuticals' plecanatide shows positive results in Phase 2B study
Yahoo/Fly on the Wall
Wednesday, April 30, 2014 - 12:58pm
tags:
Synergy Pharmaceuticals, plecanatide, IBS-C

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.